Show an ad over header. AMP

Coronavirus cases increase in 17 states

Data: The COVID Tracking Project, state health departments; Map: Andrew Witherspoon, Sara Wise/Axios

Coronavirus infections ticked up slightly over the past week, thanks to scattered outbreaks in every region of the country.

Where it stands: The U.S. has been making halting, uneven progress against the virus since August. Overall, we're moving in the right direction, but we're often taking two steps forward and one step back.


By the numbers: The U.S. saw an average of about 37,000 new cases per day over the past week. The daily rate of new cases increased in 17 states and declined in 13.

  • Testing fell by over 6% from the week before. The U.S. averaged just under 695,000 tests per day.
  • There's no clear geographic trend at work. Since the mid-summer surge across the Sun Belt subsided, new outbreaks have been driven largely by one-off, localized events, like college campuses reopening.

How it works: Each week, Axios tracks the change in new infections in each state. We use a seven-day average to minimize the effects of day-to-day discrepancies in states’ reporting.

Biden explains justification for Syria strike in letter to congressional leadership

President Biden told congressional leadership in a letter Saturday that this week's airstrike against facilities tied to Iranian-backed militia groups in Syria was consistent with the U.S. right to self-defense.

Why it matters: Some Democrats, including Sens. Tim Kaine (D-Va.) and Chris Murphy (D-Conn.) and Rep. Ro Khanna (D-Calif.), have criticized the Biden administration for the strike and demanded a briefing.

Keep reading... Show less

FDA authorizes Johnson & Johnson's one-shot COVID-19 vaccine for emergency use

The Food and Drugs Administration on Saturdayissued an emergency use authorization for Johnson & Johnson's one-shot coronavirus vaccine.

Why it matters: The authorization of a third coronavirus vaccine in the U.S. will help speed up the vaccine rollout across the country, especially since the J&J shot only requires one dose as opposed to Moderna and Pfizer-BioNTech's two-shot vaccines.

Keep reading... Show less

Italy tightens COVID restrictions for 5 regions amid warnings of a growing prevalence of variants

Italy on Saturday announced it was tightening restrictions in five of the country's 20 regions in an effort curb the spread of the coronavirus.

Driving the news: The announcement comes as health experts and scientists warn of the more transmissible coronavirus variants, per Reuters.

Keep reading... Show less

Palestinian Authority announces new COVID restrictions as cases surge

The Palestinian Authority on Saturday announced fresh coronavirus restrictions, including a partial lockdown, for the occupied West Bank as COVID-19 cases surge.

The big picture: The new measures come as Israel, which leads the world in vaccinations, faces increased pressure to ensure Palestinians in the occupied West Bank and Gaza Strip have equal access to vaccines.

Keep reading... Show less

Myanmar military fires UN ambassador after anti-coup speech

Myanmar's military regime on Saturday fired the country's Ambassador to the United Nations, Kyaw Moe Tun, a day after he gave a pro-democracy speech asking UN member nations to publicly condemn the Feb. 1 coup, The New York Times reports.

Details: State television said the ambassador had "betrayed the country and spoken for an unofficial organization which doesn’t represent the country and had abused the power and responsibilities of an ambassador."

Keep reading... Show less

Scoop: Biden admin call on Putin pipeline provokes GOP anger

A briefing between the State Department and congressional staff over Vladimir Putin's Russia-Germany gas pipeline got tense this week, with Biden officials deflecting questions about why they hadn't moved faster and more aggressively with sanctions tostop its completion.

  • The Biden officials also denied negotiating with the Germans over a potential side deal to allow the pipeline to be finished.
Keep reading... Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories